Monopar Therapeutics Inc.

39.81
-1.58 (-3.82%)
At close: Mar 28, 2025, 3:59 PM
41.91
5.26%
After-hours: Mar 28, 2025, 04:49 PM EDT

Monopar Therapeutics Statistics

Share Statistics

Monopar Therapeutics has 6.1M shares outstanding. The number of shares has increased by -59.13% in one year.

Shares Outstanding 6.1M
Shares Change (YoY) -59.13%
Shares Change (QoQ) 72.61%
Owned by Institutions (%) 2.62%
Shares Floating 3.95M
Failed to Deliver (FTD) Shares 1.59K
FTD / Avg. Volume 3.05%

Short Selling Information

The latest short interest is 49.85K, so 0.82% of the outstanding shares have been sold short.

Short Interest 49.85K
Short % of Shares Out 0.82%
Short % of Float 1.07%
Short Ratio (days to cover) 0.15

Valuation Ratios

The PE ratio is -2.94 and the forward PE ratio is -15.76. Monopar Therapeutics's PEG ratio is 0.1.

PE Ratio -2.94
Forward PE -15.76
PS Ratio 0
Forward PS 3.1
PB Ratio 4.41
P/FCF Ratio -3.14
PEG Ratio 0.1
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Monopar Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.

Current Ratio 4.17
Quick Ratio 4.17
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -1.5% and return on capital (ROIC) is -158.05%.

Return on Equity (ROE) -1.5%
Return on Assets (ROA) -1.14%
Return on Capital (ROIC) -158.05%
Revenue Per Employee $0
Profits Per Employee $-933,577.33
Employee Count 9
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 1081.82% in the last 52 weeks. The beta is 1.19, so Monopar Therapeutics's price volatility has been higher than the market average.

Beta 1.19
52-Week Price Change 1081.82%
50-Day Moving Average 37.82
200-Day Moving Average 17.15
Relative Strength Index (RSI) 58.68
Average Volume (20 Days) 52.19K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -8.83M
Net Income -8.4M
EBITDA 429.04K
EBIT n/a
Earnings Per Share (EPS) -0.58
Full Income Statement

Balance Sheet

The company has 7.27M in cash and 0 in debt, giving a net cash position of 7.27M.

Cash & Cash Equivalents 7.27M
Total Debt 0
Net Cash 7.27M
Retained Earnings -60.21M
Total Assets 6.07M
Working Capital 4.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.86M and capital expenditures 0, giving a free cash flow of -7.86M.

Operating Cash Flow -7.86M
Capital Expenditures 0
Free Cash Flow -7.86M
FCF Per Share -0.54
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -1.44%
FCF Yield -3.2%
Dividend Details

Analyst Forecast

The average price target for MNPR is $45, which is 11.7% higher than the current price. The consensus rating is "Buy".

Price Target $45
Price Target Difference 11.7%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Aug 13, 2024. It was a backward split with a ratio of 1:5.

Last Split Date Aug 13, 2024
Split Type backward
Split Ratio 1:5

Scores

Altman Z-Score 104.75
Piotroski F-Score 2